SCHEMBL20233191

SCHEMBL20233191

CC(F)CC(F)CNC=O

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 3/20 0.52
ADH1A P07327 3/20 0.52
ADH1C P00326 2/20 0.52
ADH7 P40394 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL514885 0.80
SCHEMBL309380 0.69
SCHEMBL26236 0.69
SCHEMBL13283251 0.69 ADH1B (0.68) ADH1BADH1AADH1CADH7
SCHEMBL19390046 0.67
SCHEMBL13066109 0.67
SCHEMBL22668472 0.67
SCHEMBL15172204 0.67 ADH1B (0.64) ADH1BADH1AADH1CADH7
SCHEMBL740044 0.67
SCHEMBL14069437 0.67 ADH1B (0.56) ADH1BADH1AADH1CADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018102485-A1 TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-07 WO disclosed